Suppr超能文献

评价以重组 MIP 和 CPAF 作为新型疫苗接种对绵羊地方性流产的保护和免疫反应。

Evaluation of protective and immune responses following vaccination with recombinant MIP and CPAF from Chlamydia abortus as novel vaccines for enzootic abortion of ewes.

机构信息

School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland; Animal & Bioscience Department, Teagasc Grange, Dunsany, Co. Meath, Ireland.

Animal & Bioscience Department, Teagasc Grange, Dunsany, Co. Meath, Ireland.

出版信息

Vaccine. 2019 Aug 23;37(36):5428-5438. doi: 10.1016/j.vaccine.2019.06.088. Epub 2019 Jul 30.

Abstract

MIP and CPAF from Chlamydia have been shown to be effective in inducing immune responses important in clearing chlamydial infections. This study evaluates the protection conferred by MIP and CPAF as novel vaccines in pregnant C. abortus challenged ewes. Fifty C. abortus sero-negative sheep were randomly allocated into 5 groups of 10 according to the treatment they were to receive (1) 100 µg of MBP-MIP (2) 100 µg CPAF (3) 50 µg MBP-MIP and 50 µg CPAF (4) Tris-buffer (negative control) (5) Enzovax (positive control). Booster inoculations were administered 3 weeks after primary inoculations. Blood samples were taken pre-vaccination and weekly for 5 weeks. Five months after vaccination the ewes were mated. Pregnant ewes were then challenged on day 90 of gestation. Blood samples taken at four time-points post challenge were analysed for IFNγ levels, TNFα and IL-10 expression and anti-chlamydial antibody levels. Vaginal swabs, placental and foetal tissue and bacterial shedding were analysed using qPCR to quantify levels of C. abortus. Enzovax was 100% effective with no abortions occurring. The MIP/CPAF combined vaccine offered the greatest protection of the novel vaccines with 67% of ewes giving birth to one or more live lambs equating to a 50% vaccine efficacy rate. MIP and CPAF administered singly did not confer protection. Enzovax and MIP/CPAF vaccinated ewes had longer gestations and lambs with higher birth weights than negative control ewes. Aborting ewes shed higher numbers of C. abortus than ewes that had live lambs, all vaccinated ewes demonstrated lower levels of bacterial shedding than negative control ewes with Enzovax ewes shedding significantly fewer bacteria. Ewes that went on to abort had significantly higher levels of IFNγ and IL-10 at day 35 post challenge and significantly higher levels of anti-chlamydial antibodies at 24 h post lambing compared to ewes that had live lambs.

摘要

衣原体的 MIP 和 CPAF 已被证明可有效诱导清除衣原体感染的重要免疫反应。本研究评估了 MIP 和 CPAF 作为新型疫苗在感染衣原体的怀孕母羊中的保护作用。50 只血清阴性的绵羊按接受的处理随机分为 5 组,每组 10 只:(1)100μg MBP-MIP(2)100μg CPAF(3)50μg MBP-MIP 和 50μg CPAF(4)Tris 缓冲液(阴性对照)(5)Enzovax(阳性对照)。初次接种后 3 周进行加强接种。接种前和接种后每周采集血样 5 周。接种 5 个月后,母羊交配。然后在妊娠第 90 天对怀孕母羊进行攻毒。攻毒后 4 个时间点采集血样,分析 IFNγ 水平、TNFα 和 IL-10 表达以及抗衣原体抗体水平。用 qPCR 分析阴道拭子、胎盘和胎牛组织以及细菌脱落物,以定量分析流产衣原体。Enzovax 接种的母羊 100%有效,无流产发生。MIP/CPAF 联合疫苗是新型疫苗中保护效果最好的,67%的母羊产下 1 只或多只活羔羊,疫苗有效率为 50%。单独接种 MIP 和 CPAF 不能提供保护。接种 Enzovax 和 MIP/CPAF 的母羊的妊娠期较长,羔羊的出生体重较高,与阴性对照母羊相比。流产母羊的流产衣原体数量高于产活羔羊的母羊,所有接种母羊的细菌脱落量均低于阴性对照母羊,而 Enzovax 接种母羊的细菌脱落量显著减少。继续流产的母羊在攻毒后 35 天 IFNγ 和 IL-10 水平显著升高,产后 24 小时抗衣原体抗体水平显著升高与产活羔羊的母羊相比。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验